U of T to Transform Regenerative Medicine with $114-million Federal Grant

The University of Toronto is set to cement its position as one of the world’s leading centres for the design and manufacture of cells, tissues and organs that can be used to treat degenerative disease, thanks to a $114-million grant from the federal government.

The research grant, the largest in U of T’s history, is the first to be awarded under the Canada First Research Excellence Fund (CFREF), established by the federal government last year. Spread over seven years, the funding will allow U of T and its partners, which include the Hospital for Sick Children, the University Health Network and Mount Sinai Hospital, to deliver a new program called Medicine by Design. The initiative and the new funding build on years of support for U of T’s regenerative medicine researchers from federal granting councils, the Canada Foundation for Innovation and support from the Canada Research Chairs and Canada Excellence Research Chairs programs. Read full story.

More than 50 researchers and clinicians at the University of Toronto and its partner hospitals are participating in Medicine By Design. Among its experts are ProfessorPeter Zandstra (IBBME), one of the key leaders, and University Professor Molly Shoichet (IBBME, ChemE) of the Faculty of Applied Science & Engineering. Both Shoichet and Zandstra work with stem cells, which have the ability to become any type of cell in the human body, and could one day be used to repair or replace damaged tissues. Writer Tyler Irving spoke with Shoichet and Zandstra about how Medicine by Design will change lives. Read more.